Apyx Medical Corp. (NASDAQ: APYX) reported Q2 EPS of ($0.03), $0.04 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $13.57 million versus the consensus estimate of $14.33 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.